AMZN
Amazon.com, Inc.
AMZN has the edge over HDL overall, supported by stronger modeled upside and stronger valuation.
HDL
SUPER HI INTERNATIONAL HOLDING Ltd. American Depositary Shares
HDL trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
HDL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
HDL's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over HDL in the historical PE scenario, which offers more potential upside but is not a forecast.
HDL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $5.44 | -49% |
| Fair | 22x | $5.94 | -44% |
| Expensive | 34x | $9.06 | -15% |
| Current | 40x | $10.69 | — |
Historical ranges are pointers, not guarantees.
HDL's PE is 40x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
HDL Forward outlook
There aren't enough analyst estimates for HDL to show an outlook.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over HDL in the latest year-over-year earnings comparison.
HDL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.27 | -70% |
HDL's earnings per share have fallen from their peak: $0.27 over the past year, against $0.90 in mid-2025.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over HDL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over HDL on profitability, with a higher operating margin.
HDL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $218.7M | +9.9% |
| Q1 2026 | $225.9M | +14% |
| Q4 2025 | $230.3M | +9.6% |
| Q3 2025 | $214M | +7.8% |
| Q2 2025 | $199M | +9.1% |
| Q1 2025 | $197.8M | +4.9% |
| Q4 2024 | $210.1M | +10% |
| Q3 2024 | $198.6M | +15% |
HDL's revenue has grown year over year every quarter since early 2022: $219M last quarter, up 9.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.3% | -15 points |
| Q1 2026 | 6.5% | -17 points |
| Q4 2025 | 7.3% | -19 points |
| Q3 2025 | 6% | -21 points |
| Q2 2025 | 20% | -2.1 points |
| Q1 2025 | 24% | -2.6 points |
| Q4 2024 | 26% | +2.7 points |
| Q3 2024 | 27% | +1.9 points |
HDL's operating margin was 4.3% last quarter, down 15 points from the same quarter a year ago, near the bottom of its range since 2021.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
HDL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $28.2M | +6.2% |
| Q1 2026 | $24.2M | +107673% |
| Q4 2025 | $2.7M | -79% |
| Q3 2025 | $34.1M | -16% |
| Q2 2025 | $26.6M | +11% |
| Q1 2025 | $22.5K | -100% |
| Q4 2024 | $12.8M | -27% |
| Q3 2024 | $40.7M | +133% |
HDL has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over HDL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
HDL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +44% | +17.9M shares |
| 1 year | +7.5% | +4.1M shares |
HDL has 59M diluted shares, up 7.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HDL hasn't bought back shares in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HDL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 1.0x | Very low |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.4x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
HDL's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
HDL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.9 | Neutral |
| Stochastic | 9.0 | Oversold |
HDL's weekly RSI is 38 (neutral) and its Stochastic is 9 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over HDL on valuation relative to its sector.
HDL PE vs Consumer Cyclical Sector
| Metric | HDL | Sector median | Relative |
|---|---|---|---|
| PE | 40x | 18x | 121% above |
| PE % | 100 | 23 | 77 pts above |
HDL is trading at 40x earnings, a 121% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has stronger trend alignment. AMZN is above 5 of 5 weekly averages versus HDL above 0 of 4.
HDL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.8 | 0.6% below |
| 20 week MA | $12.0 | 11% below |
| 50 week MA | $14.0 | 24% below |
| 100 week MA | $17.6 | 39% below |
HDL is in a downtrend: it's below all four of its weekly moving averages, and 39% below its 100-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over HDL on returns for 2026, with the stronger performance.
HDL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $22.3 | $27.3 | +22% |
| 2025 | $27.3 | $16.3 | -40% |
| 2026 YTD | $16.3 | $10.7 | -34% |
HDL has finished lower in one of the last two years. It's down 34% so far in 2026.